Abstract:Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, including Australia. The absence of a consensus clinical practice guideline (CPG) specific to HCC management poses challenges in reducing morbidity, mortality, and improving patient recovery. This systematic review aims to evaluate the existing evidence and assess the potential of published guidelines, including those with an international scope, to provide guidance for healthcare professionals in Australia. Methods: Electronic search of MEDLINE, Embase, Cochrane Library, Google Scholar, and PubMed was conducted. Peer-reviewed English language articles from 2005 to June 2022 were included if they described management of HCC as part of an evidence-based overall management plan or CPG. The quality of the included CPGs was assessed by the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Results: Twenty-one articles from 16 regions throughout the world were included in this review. All included guidelines (n = 21, 100%) recommended evaluating cirrhosis, hepatitis B, and hepatitis C as potential risk factors of HCC. Obesity and non-alcoholic fatty liver disease were recommended by 19 CPGs (91%) as risk factor for HCC. Fourteen guidelines (67%) endorsed using the BCLC staging system. Eighteen guidelines (86%) recommended a multidisciplinary approach for the management of HCC. Eighteen guidelines (86%) advised that surveillance using ultrasound should be implemented in all cirrhotic patients every 6 months regardless of the cause of cirrhosis. AGREE II mean overall assessment score was 90% indicating that all guidelines included were highly recommended in majority of domains. Conclusions: The included CPGs provided a comprehensive approach, emphasizing the evaluation of risk factors, utilization of the BCLC staging system, and the importance of a multidisciplinary approach. Regular surveillance using ultrasound for cirrhotic patients was widely recommended. An understanding of contemporary international CPGs can prioritize aspects of the management of HCC to assist healthcare professionals to develop a national guideline to enable standardized, comprehensive, and evidence-based care for patients with HCC.

World Gastroenterology Organisation Guideline. Hepatocellular Carcinoma (HCC): a Global Perspective.

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

O-13 SUB-OPTIMAL GLOBAL PUBLIC HEALTH POLICIES AND STRATEGIES TO TACKLE HEPATOCELLULAR CARCINOMA

British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults

APASL Clinical Practice Guidelines on Systemic Therapy for Hepatocellular Carcinoma-2024

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients with Intermediate and Advanced/relapsed Hepatocellular Carcinoma: a TOS-ESMO Initiative Endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Summary of key guidelines for locoregional treatment of HCC in Asia, Europe, South and North America

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review

Asian Pacific Association for the Study of the Liver Consensus Statements on the Diagnosis, Management and Treatment of Hepatitis C Virus Infection

SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)

Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements

Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma

Clinical Practice Guidelines and Real-Life Practice in Hepatocellular Carcinoma: A Chinese Perspective

Hepatocellular Carcinoma from a Hepatologist's Perspective

Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Chinese Expert Consensus on Refined Diagnosis, Treatment, and Management of Advanced Primary Liver Cancer (2023 Edition)

Holistic Management of Hepatocellular Carcinoma: The Hepatologist's Comprehensive Playbook